April 6, 2026 Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma: Phase 3 IsKia Trial
April 4, 2026 Real-World Clinical Utility of Tumor Whole-Genome Sequencing in Solid Cancers: Correction
